Skip to main content
Clinical Trials/CTRI/2025/02/080479
CTRI/2025/02/080479Not yet recruitingNot Applicable

Comparative evaluation of immediate versus delayed loading on peri-implant bone levels and tgf-alpha levels in peri-implant crevicular fluid - A clinico-biochemical study

SHREYA MISHRA1 site in 1 country16 target enrollmentStarted: February 24, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
16
Locations
1
Primary Endpoint
To evaluate and compare levels of TGF –alpha in PICF around immediate and delayed loaded implants at 15 days, 1 month and at 3 months and to evaluate and compare the marginal bone loss at baseline to 3 months

Study Overview

Brief Summary

Introduction - According to Albrektsson (1993), a successful implant should sustain less than 1.5 mm of bone loss during the first year and less than 0.2mm annually thereafter. The assessment of marginal bone loss around implants is carried out by means of periapical radiographs and more recent advances like cbct. Another important aspect is primary and secondary implant stability. Primary implant stability directly dependents on bone quality. A promising tool for assessing peri-implant bone formation is the detection of specific biomarkers in peri-implant crevicular fluid. Tgf-alpha is an important biomarker during the first stages of osseointegration, a fibrin-rich vascularized matrix populated by fibroblast-like cells is created providing a template for future bone.

Aim - the aim of this present study is to evaluate and compare the peri-implant bone loss between immediate and delayed loaded implants.

Materials & methods - For group a, 8 sites indicated for replacement of missing tooth with more than 6mm width and 10mm height of bone will be taken for implant placement with immediate loading followed by placement of healing abutment. Acrylic crown will be placed within 72hrs. For group b, 8 sites indicated for replacement of missing tooth with sufficient height of bone will be taken for implant placement with delayed loading followed by placement of healing abutment. Picf samples will be collected at 15 days, 30 days and 90 days. Isq and crestal bone levels will be measured at baseline and 3 months.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Subjects aged above 18 years requiring Implant placement.
  • Patients with adequate oral hygiene status
  • No active periodontal disease
  • Sufficient bone quality (D1, D2 and D3) and quantity
  • Proper inter-occlusal space in missing tooth region
  • Patients who are willing to comply with the treatment protocol
  • Extraction must be done at least 3 months prior to treatment.

Exclusion Criteria

  • Patients with uncontrolled diabetes.
  • Patients with autoimmune diseases, psychiatric disorders, osteoporosis
  • Patients undergoing or who underwent radiation therapy and chemotherapy to the head and neck region during the last 12 months
  • Patients with poor oral hygiene
  • Alcoholic, drug abusers and heavy smokers
  • Pregnant and lactating women
  • Sites with acute infection.

Outcomes

Primary Outcomes

To evaluate and compare levels of TGF –alpha in PICF around immediate and delayed loaded implants at 15 days, 1 month and at 3 months and to evaluate and compare the marginal bone loss at baseline to 3 months

Time Frame: Baseline- 3 months

Secondary Outcomes

  • Comparision of bleeding on probing and ISQ measurements between immediate and delayed loaded implants at baseline and 3 months.(Baseline- 3 months)

Investigators

Sponsor
SHREYA MISHRA
Sponsor Class
Other [PRIVATE DENTAL COLLEGE]
Responsible Party
Principal Investigator
Principal Investigator

SHREYA MISHRA

ITS DENTAL COLLEGE

Study Sites (1)

Loading locations...

Similar Trials